Cargando…
Serum interleukin‐33 as a novel marker for long‐term prognosis and recurrence in acute ischemic stroke patients
OBJECTIVES: Interleukin‐33, a newly identified member of interleukin‐1 family, had been confirmed to play a crucial role in regulating inflammatory responses in various disease. However, the exact role of interleukin‐33 in the disease process of acute ischemic stroke still remains unclear. This stud...
Autores principales: | Li, Xian‐Mei, Wang, Xiao‐yang, Feng, Xiao‐Wen, Shao, Meng‐Meng, Liu, Wen‐Fang, Ma, Qin‐Qin, Wang, En‐Pei, Chen, Jie, Shao, Bei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749472/ https://www.ncbi.nlm.nih.gov/pubmed/31397082 http://dx.doi.org/10.1002/brb3.1369 |
Ejemplares similares
-
Serum IL-33 Is a Novel Diagnostic and Prognostic Biomarker in Acute Ischemic Stroke
por: Li, Qian, et al.
Publicado: (2016) -
Serum Interleukin-37 Increases in Patients after Ischemic Stroke and Is Associated with Stroke Recurrence
por: Zhang, Ying, et al.
Publicado: (2021) -
Role of sLOX‐1 in intracranial artery stenosis and in predicting long‐term prognosis of acute ischemic stroke
por: Li, Xian‐Mei, et al.
Publicado: (2017) -
Interleukin-6 and YKL-40 predicted recurrent stroke after ischemic stroke or TIA: analysis of 6 inflammation biomarkers in a prospective cohort study
por: Li, Jiejie, et al.
Publicado: (2022) -
Interleukin-17 receptor C gene polymorphism reduces treatment effect and promotes poor prognosis of ischemic stroke
por: Tian, Jing, et al.
Publicado: (2019)